The estimated Net Worth of Keith J Sullivan is at least $4.7 Million dollars as of 18 July 2024. Mr Sullivan owns over 24,162 units of Neuronetics Inc stock worth over $980,022 and over the last 7 years he sold STIM stock worth over $2,890,977. In addition, he makes $832,675 as Pres and CEO & Director at Neuronetics Inc.
Mr has made over 19 trades of the Neuronetics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 24,162 units of STIM stock worth $45,908 on 18 July 2024.
The largest trade he's ever made was exercising 100,000 units of Neuronetics Inc stock on 20 October 2022 worth over $198,000. On average, Mr trades about 14,667 units every 54 days since 2017. As of 18 July 2024 he still owns at least 1,324,354 units of Neuronetics Inc stock.
You can see the complete history of Mr Sullivan stock trades at the bottom of the page.
Keith J. Sullivan is the Pres, CEO & Director at Neuronetics Inc.
As the Pres and CEO & Director of Neuronetics Inc, the total compensation of Mr Sullivan at Neuronetics Inc is $832,675. There are 3 executives at Neuronetics Inc getting paid more, with Daniel Guthrie having the highest compensation of $1,937,180.
Mr Sullivan is 63, he's been the Pres and CEO & Director of Neuronetics Inc since . There are 1 older and 12 younger executives at Neuronetics Inc. The oldest executive at Neuronetics Inc is Wilfred Jaeger, 64, who is the Independent Director.
Keith's mailing address filed with the SEC is C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355.
Over the last 6 years, insiders at Neuronetics Inc have traded over $9,582,393 worth of Neuronetics Inc stock and bought 1,499,267 units worth $4,708,316 . The most active insiders traders include Capital Llc Cannell, Ronald Hunt, and Glenn P Muir. On average, Neuronetics Inc executives and independent directors trade stock every 20 days with the average trade being worth of $21,199. The most recent stock trade was executed by Glenn P Muir on 5 September 2024, trading 25,000 units of STIM stock currently worth $20,000.
with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the first company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
Neuronetics Inc executives and other stock owners filed with the SEC include: